The purpose of the agreement is to isolate acute myeloid leukaemia stem cells and generate monoclonal antibodies against these cells to help develop new therapies, the French pharmaceuticals group said on Friday.

• 周五这家法国制药集团表示，这项合作的目的是分离急性髓系白血病干细胞，生产针对这些细胞的单克隆抗体，从而开发新的疗法。